title: [Efficacy and safety of pancrealipase delayed-release capsules (Creon) in patients with pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery].
abstract: In the article design, objectives, methods of conducting double-blind, randomized study which results prove efficacy and safety of new formulation of Creon are presented.
authors.forename: D
authors.initials: D
authors.lastname: Vitkomb
authors.forename: E
authors.initials: E
authors.lastname: Maleska-Panas
authors.forename: G
authors.initials: G
authors.lastname: Lekhman
authors.forename: N
authors.initials: N
authors.lastname: Vasil'eva
authors.forename: N
authors.initials: N
authors.lastname: Gubergrits
authors.forename: S
authors.initials: S
authors.lastname: Karas
authors.forename: Ia
authors.initials: Ia
authors.lastname: Shen
authors.forename: S
authors.initials: S
authors.lastname: Sander-Strukmaer
mesh_terms: D000328:Adult; D004311:Double-Blind Method; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism / Q000601:surgery*; D050500:Pancreatitis, Chronic / Q000378:metabolism / Q000628:therapy*; D020799:Pancrelipase / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D005765:Gastrointestinal Agents; D020799:Pancrelipase